Notably, targeting CLTC, a critical RLRG, can effectively inhibit R-loop-mediated lipid metabolic reprogramming, and suppress the proliferation and migration of HCC, which suggests that R-loops could serve as potential therapeutic targets and prognostic biomarkers for HCC. The gene discussed is CLTC; the disease is hepatocellular carcinoma.